---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-237203"
form_type: "8-K"
ticker: null
cik: "0001618921"
company_name: "Walgreens Boots Alliance, Inc."
filed_at: "2024-10-15T23:59:59+00:00"
generated_at: "2026-05-30T14:36:13.823409+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Walgreens reports FY2024 loss of $10.01/sh, plans to close 1,200-1,300 stores by 2027

## Summary
- Q4 loss per share $3.48 (incl. $0.39 adj. EPS, down 40.8% YoY); revenue $37.5B (+6.0%).
- FY2024 loss per share $10.01; adjusted EPS $2.88 (-27.9%); revenue $147.7B (+6.2%).
- Footprint Optimization: close ~900-1,000 stores by FY2027, plus 300 from prior program for total 1,200-1,300; ~500 in FY2025.
- Pre-tax charges $2.2-2.4B (lease $1.8-2.0B, impairments $300M, severance $100M); program accretive to cash flow starting FY2025.
- FY2025 adjusted EPS guidance $1.40-1.80; expects Healthcare and Intl growth offset by U.S. Retail decline.

## SEC filing metadata
- accession: 0001193125-24-237203
- form_type: 8-K
- cik: 0001618921
- company_name: Walgreens Boots Alliance, Inc.
- filed_at: 2024-10-15T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 7.01, 2.05, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1618921/000119312524237203/0001193125-24-237203-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1618921/000119312524237203/d870298d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-237203
- JSON: https://secwatch.observer/filing/0001193125-24-237203.json
- Plain text: https://secwatch.observer/filing/0001193125-24-237203.txt

## Key facts
- Restructurings & Charges
  Walgreens Boots Alliance, Inc. announced a restructuring with charges of approximately $2.2 billion to $2.4 billion affecting U.S. Retail Pharmacy segment.
  - Type: restructuring
  - Charge: approximately $2.2 billion to $2.4 billion
  - Affected area: U.S. Retail Pharmacy segment
  source text: the workforce in those stores that are closed. The Company currently estimates that it will recognize cumulative pre-tax charges to its GAAP financial results of approximately $2.2 billion to $2.4 billion, including costs associated with lease obligations and other real estate costs, asset impairments, and employee severance and other exit costs. The Company
  evidence_url: https://www.sec.gov/Archives/edgar/data/1618921/000119312524237203/0001193125-24-237203-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.